Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Global bio-chem TechnoloGy Group company limiTed

*

(incorporated in the Cayman Islands with limited liability)

(Stock code: 00809) proFiT WarninG

This announcement is made by the Company pursuant to Rule 13.09 of the Listing Rules and Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong).
The Board wishes to inform the shareholders of the Company and potential investors that based on the preliminary review of the draft unaudited consolidated management accounts of the Group for the six months ended 30 June 2014 and other information currently available to the Board, it is expected that the net loss for the six months ended 30 June 2014 will be increased significantly as compared to the net loss minus impairment loss of properly, plant and equipment for the six months ended 30 June 2013.
Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

This announcement is made by Global Bio-chem Technology Group Company Limited (the "company", together with its subsidiaries, the "Group ") pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited ("listing rules") and Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Cap.
571 of the Laws of Hong Kong).
The board (the "board") of directors (the "directors") of the Company wishes to inform the shareholders of the Company and potential investors that based on the preliminary review of the draft unaudited consolidated management accounts of the Group for the six months ended 30 June
2014 and other information currently available to the Board, it is expected that the net loss for the six months ended 30 June 2014 (the "period") will be increased significantly as compared to the net loss minus impairment loss of properly, plant and equipment for the six months ended 30 June 2013.

* for identification purpose only

- 1 -
The Directors consider that such significant increase in net loss was mainly attributable to the decline in the average selling prices and demand of the Group's products and the impairment for the inventories of the products of the Group due to the decrease of selling prices. The net loss for the six months ended 30 June 2013 was approximately HK$1,566 million, which comprised of, among others, an impairment loss of property, plant and equipment in the amount of approximately HK$581 million. It is expected that the net loss for the Period will be significantly higher than HK$985 million (which is the total net loss for the six months ended 30 June 2013 in the amount of approximately HK$1,566 million minus impairment loss of property, plant and equipment of approximately HK$581 million for the six months ended 30 June 2013). As of the date of this announcement, the Board has not decided whether any impairment of property, plant and equipment will be made in respect the Period. If such impairment will be made, the financial performance of the Group will be further adversely affected.
The Board wishes to emphasize that the unaudited consolidated financial results of the Group for the Period have not been finalized. Detailed financial results of the Group for the Period will be disclosed in the interim results announcement and interim report which are expected to be published by the end of August 2014 and September 2014 respectively.

Shareholders of the company and the potential investors are advised to exercise caution when dealing in the shares of the company.

By order of the Board

Global bio-chem Technology Group company limited liu Xiaoming

Chairman

Hong Kong, 28 July 2014

As at the date of this announcement, the board of Directors comprises four executive Directors, namely Mr. Liu Xiaoming, Ms. Xu Ziyi, Mr. Li Weigang and Mr. Wang Yongan and three independent non-executive Directors, namely Mr. Chan Man Hon, Eric, Mr. Lee Yuen Kwong and Mr. Li Defa.

- 2 -

distributed by